Showing results (41-50 of 194) with videos related to
Sort By:
Pageof 20
Science Bulletin|January 20, 2023
The role of collateral related donors in haploidentical hematopoietic stem cell transplantationXiao-Dong Mo, Yuan-Yuan Zhang, Xiao-Hui Zhang, et al.Transplantation and Cellular Therapy|February 10, 2026
Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodiesNing Ma, Xiang-Yu Zhao, Lan-Ping Xu, et al.American Journal of Hematology|March 16, 2022
Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacyXu-Ying Pei, Xiang-Yu Zhao, Xue-Fei Liu, et al.Journal for Immunotherapy of Cancer|March 30, 2020
Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignanciesJiangying Liu, Haitao Gao, Lan-Ping Xu, et al.Blood Science (Baltimore, Md.)|May 23, 2024
Plerixafor-based mobilization and mononuclear cell counts in graft increased the risk of engraftment syndrome after autologous hematopoietic stem cell transplantationLe-Qing Cao, Qi Wen, Bo-Ning Liu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2016
Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction ChemotherapyXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.Respiration; International Review of Thoracic Diseases|January 9, 2013
High-dose cyclophosphamide therapy associated with diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantationXiao-Dong Mo, Lan-Ping Xu, Dai-Hong Liu, et al.European Journal of Haematology|May 27, 2015
Salvage chemotherapy followed by granulocyte colony-stimulating factor-primed donor leukocyte infusion with graft-vs.-host disease control for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: prognostic factors and clinical outcomesXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 25, 2026
Loss of SOCS1 in Donor T Cells Exacerbates Intestinal GVHD by Driving a Chemokine-Dependent Pro-Inflammatory Immune MicroenvironmentZhigui Wu, Bixia Wang, Xinya Jiang, et al.Chinese Medical Journal|August 29, 2013
Health related quality of life among patients with chronic graft-versus-host disease in ChinaXiao-dong Mo, Lan-ping Xu, Dai-hong Liu, et al.Pageof 20